A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells-Reference-Cited by-同舟云学术

A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells

Published:2022-03 Issue:6 Volume:82 Page:1123-1139.e8
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Shen Jia Z.,Qiu Zhixin,Wu Qiulian,Zhang Guoxin,Harris Rebecca^ORCID,Sun Dahui,Rantala Juha,Barshop William D.,Zhao Linjie,Lv Deguan,Won Kwang-Ai,Wohlschlegel James,Sangfelt Olle,Laman Heike^ORCID,Rich Jeremy N.,Spruck Charles

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference69 articles.

1. Molecular pathways: oncologic pathways and their role in T-cell exclusion and immune evasion-A new role for the AXL receptor tyrosine kinase;Aguilera;Clin. Cancer Res.,2017

2. Reprogramming the immunological microenvironment through radiation and targeting Axl;Aguilera;Nat. Commun.,2016

3. AXL-driven EMT state as a targetable conduit in cancer;Antony;Cancer Res.,2017

4. TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma;Bertrand;Nat. Commun.,2017

5. The SIX1-EYA transcriptional complex as a therapeutic target in cancer;Blevins;Expert Opin. Ther. Targets,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma;Nature Communications;2024-06-05

2. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

3. Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co‐regulate proteasomes and mitochondria;The FEBS Journal;2024-03-11

4. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma;Scientific Reports;2024-01-30

5. Advances in targets in inflammatory breast cancer;International Review of Cell and Molecular Biology;2024